Pasireotide for the Medical Management of Feline Hypersomatotropism.
about
What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation.Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.Medical management of gastrinoma in a cat.Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment.
P2860
Pasireotide for the Medical Management of Feline Hypersomatotropism.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@en
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@nl
type
label
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@en
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@nl
prefLabel
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@en
Pasireotide for the Medical Management of Feline Hypersomatotropism.
@nl
P2093
P2860
P356
P1476
Pasireotide for the Medical Management of Feline Hypersomatotropism
@en
P2093
C J Scudder
H A Schmid
S J M Niessen
P2860
P304
P356
10.1111/JVIM.12608
P50
P577
2015-05-06T00:00:00Z